A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI‐2173 in patients with chronic hepatitis B virus infection

por Squires, Katherine E., Ogilvie, Lauren, Jucov, Alina, Anastasiy, Igor, Ghicavii, Nelli, Huguet, Jade, Melara, Rebeca, Constantineau, Martin, De La Rosa, Abel, Mayers, Douglas L.
Publicado 2022

Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions

por Colombo, Massimo Giuseppe, Musabaev, Erkin Isakovich, Ismailov, Umed Yusupovich, Zaytsev, Igor A, Nersesov, Alexander V, Anastasiy, Igor Anatoliyevich, Karpov, Igor Alexandrovich, Golubovska, Olga A, Kaliaskarova, Kulpash S, AC, Ravishankar, Hadigal, Sanjay
Publicado 2019